Hepatitis C;
primary care physician;
disease workup;
patient monitoring;
barriers to treatment;
THERAPY;
MANAGEMENT;
PREDICTORS;
PHYSICIANS;
PATIENT;
RATES;
D O I:
10.3109/13814788.2010.545122
中图分类号:
R1 [预防医学、卫生学];
学科分类号:
1004 ;
120402 ;
摘要:
Background: The primary care physician (PCP) diagnoses chronic Hepatitis C virus (HCV) infection in most patients. He serves as gatekeeper and plays a key role in counselling and treatment guidance. Objectives: To calculate the approximate HCV caseload per practice and characterize PCPs management of the disease; in particular, to determine antiviral treatment rates and reasons for PCPs for withholding treatment. The ultimate objective was to identify potentially modifiable barriers to treatment. Methods: A confidential self-administered questionnaire centred on the above-mentioned questions was distributed to 2371 Swiss primary care physicians. All respondents of the main questionnaire received an additional small questionnaire focussed on the initial disease workup. Descriptive statistics were used to describe questionnaire responses and PCP demographics. Results : The response rate was 53.1%. Of all participating PCPs (n = 1084), 86.2% reported having patients with chronic HCV, with an average number of 4 patients per practice; 18.6% (n = 142) of PCPs did not monitor their chronic HCV patients. Two-thirds (66.8%) of the sample chronic HCV patient population (n = 4626) never received antiviral therapy. The main reasons given by PCPs for withholding treatment were HCV-specialist advice, patient preference, normal liver enzymes and patient related factors like substance abuse or psychiatric co morbidity. Conclusions: Most PCPs follow patients with chronic hepatitis C, but practice caseloads are low, which may account for insecurity in managing this complex disease.
机构:
Catholic Univ, Inst Dermatol, Policlin A Gemelli, Rome, ItalyColumbia Univ, Dept Dermatol, Med Ctr, 1150 St Nicholas Ave,Russ Berrie Pavill, New York, NY 10032 USA
机构:
Univ London Imperial Coll Sci Technol & Med, Div Med, Dept Hepatol, London W2 1PG, EnglandUniv London Imperial Coll Sci Technol & Med, Div Med, Dept Hepatol, London W2 1PG, England
Harrison, R. J.
Ettorre, A.
论文数: 0引用数: 0
h-index: 0
机构:
Univ London Imperial Coll Sci Technol & Med, Div Med, Dept Hepatol, London W2 1PG, EnglandUniv London Imperial Coll Sci Technol & Med, Div Med, Dept Hepatol, London W2 1PG, England
Ettorre, A.
Little, A. -M.
论文数: 0引用数: 0
h-index: 0
机构:
Royal Free Hosp, Anthony Nolan Res Inst, London NW3 2QG, EnglandUniv London Imperial Coll Sci Technol & Med, Div Med, Dept Hepatol, London W2 1PG, England
Little, A. -M.
Khakoo, S. I.
论文数: 0引用数: 0
h-index: 0
机构:
Univ London Imperial Coll Sci Technol & Med, Div Med, Dept Hepatol, London W2 1PG, EnglandUniv London Imperial Coll Sci Technol & Med, Div Med, Dept Hepatol, London W2 1PG, England
机构:
Catholic Univ, Inst Dermatol, Policlin A Gemelli, Rome, ItalyColumbia Univ, Dept Dermatol, Med Ctr, 1150 St Nicholas Ave,Russ Berrie Pavill, New York, NY 10032 USA
机构:
Univ London Imperial Coll Sci Technol & Med, Div Med, Dept Hepatol, London W2 1PG, EnglandUniv London Imperial Coll Sci Technol & Med, Div Med, Dept Hepatol, London W2 1PG, England
Harrison, R. J.
Ettorre, A.
论文数: 0引用数: 0
h-index: 0
机构:
Univ London Imperial Coll Sci Technol & Med, Div Med, Dept Hepatol, London W2 1PG, EnglandUniv London Imperial Coll Sci Technol & Med, Div Med, Dept Hepatol, London W2 1PG, England
Ettorre, A.
Little, A. -M.
论文数: 0引用数: 0
h-index: 0
机构:
Royal Free Hosp, Anthony Nolan Res Inst, London NW3 2QG, EnglandUniv London Imperial Coll Sci Technol & Med, Div Med, Dept Hepatol, London W2 1PG, England
Little, A. -M.
Khakoo, S. I.
论文数: 0引用数: 0
h-index: 0
机构:
Univ London Imperial Coll Sci Technol & Med, Div Med, Dept Hepatol, London W2 1PG, EnglandUniv London Imperial Coll Sci Technol & Med, Div Med, Dept Hepatol, London W2 1PG, England